Yu-Juei Hsu Selected Research

Gitelman Syndrome

1/2017	Identification of the Causes for Chronic Hypokalemia: Importance of Urinary Sodium and Chloride Excretion.
3/2015	Etiologic and therapeutic analysis in patients with hypokalemic nonperiodic paralysis.
1/2015	Thiazide-sensitive Na+ -Cl- cotransporter (NCC) gene inactivation results in increased duodenal Ca2+ absorption, enhanced osteoblast differentiation and elevated bone mineral density.
8/2012	Genotype, phenotype, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation.
12/2010	Generation and analysis of the thiazide-sensitive Na+ -Cl- cotransporter (Ncc/Slc12a3) Ser707X knockin mouse as a model of Gitelman syndrome.
4/2009	Heterozygous mutations of the sodium chloride cotransporter in Chinese children: prevalence and association with blood pressure.
5/2007	Hypocalciuria in patients with Gitelman syndrome: role of blood volume.
5/2005	Phenotype and genotype analysis in Chinese patients with Gitelman's syndrome.
2/2004	Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Juei Hsu Research Topics

Disease

12	Chronic Renal Insufficiency 10/2021 - 03/2012
9	Gitelman Syndrome 01/2017 - 02/2004
8	Inflammation (Inflammations) 03/2022 - 01/2013
7	Hypokalemia 01/2017 - 02/2004
5	Neoplasms (Cancer) 10/2021 - 01/2016
5	Alkalosis 03/2015 - 02/2004
5	Paralysis (Palsy) 03/2015 - 09/2003
4	Abdominal Aortic Aneurysm 03/2022 - 01/2016
4	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 01/2018
4	Neointima 12/2020 - 01/2016
4	Fibrosis (Cirrhosis) 01/2020 - 08/2015
3	Body Weight (Weight, Body) 08/2021 - 10/2003
3	Hypoxia (Hypoxemia) 01/2021 - 01/2016
3	Uremia 12/2020 - 02/2013
3	Proteinuria 01/2020 - 08/2014
3	Vascular Diseases (Vascular Disease) 01/2019 - 10/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 01/2018
3	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2017 - 09/2003
3	Anorexia 01/2017 - 01/2013
3	Insulin Resistance 01/2013 - 10/2003
2	Aneurysm (Aneurysms) 03/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 10/2021 - 11/2017
2	Pneumonia (Pneumonitis) 10/2021 - 01/2017
2	Hyperphosphatemia 01/2021 - 08/2020
2	Acute Lung Injury 01/2021 - 01/2017
2	Atherosclerotic Plaque (Atheroma) 12/2020 - 01/2019
2	Hyperplasia 10/2019 - 02/2013
2	Cardiomyopathies (Cardiomyopathy) 02/2018 - 08/2015
2	Bulimia Nervosa 01/2017 - 03/2015
2	Renal Insufficiency (Renal Failure) 01/2017 - 02/2013
2	Bartter Syndrome (Syndrome, Bartter) 01/2017 - 05/2005
2	Hypertrophy 08/2015 - 02/2013
2	Acidosis 03/2015 - 01/2013
2	Hyperaldosteronism (Conn Syndrome) 03/2015 - 09/2003
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 08/2014 - 08/2007
2	Hypertension (High Blood Pressure) 03/2012 - 11/2005
2	Hypotension (Low Blood Pressure) 12/2010 - 04/2009
2	Cardiac Arrhythmias (Arrythmia) 08/2010 - 03/2004
2	Hypercalciuria 04/2010 - 11/2006
1	Vascular Remodeling 03/2022
1	Ischemic Stroke 01/2022
1	Fatigue 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Myocardial Infarction 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 10/2021
1	Sarcopenia 10/2021
1	Mania (Manias) 04/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Heat Stroke (Heatstroke) 01/2021

Drug/Important Bio-Agent (IBA)

7	DiureticsIBA 01/2017 - 09/2003
5	PotassiumIBA 01/2017 - 02/2004
4	5-methoxytryptophanIBA 10/2021 - 01/2016
4	Phosphates (Orthophosphate)IBA 10/2021 - 08/2012
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2005
3	Tryptophan (L-Tryptophan)FDA Link 10/2021 - 01/2016
3	InflammasomesIBA 01/2021 - 07/2017
3	Apolipoproteins E (ApoE)IBA 12/2020 - 01/2019
3	IndicanIBA 12/2020 - 08/2015
3	CytokinesIBA 01/2020 - 01/2017
3	CreatinineIBA 09/2018 - 05/2007
3	CalciumIBA 09/2018 - 05/2007
3	SodiumIBA 01/2017 - 08/2007
3	Member 3 Solute Carrier Family 12IBA 01/2015 - 02/2004
3	Insulin (Novolin)FDA Link 01/2013 - 10/2003
3	ThiazidesIBA 08/2012 - 05/2005
2	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2019
2	Matrix Metalloproteinases (MMPs)IBA 03/2022 - 01/2016
2	Messenger RNA (mRNA)IBA 10/2021 - 01/2017
2	Muscarinic AntagonistsIBA 10/2021 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 10/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
2	Aldehyde DehydrogenaseIBA 01/2021 - 01/2020
2	Antipsychotic Agents (Antipsychotics)IBA 11/2020 - 11/2005
2	Vitamin D FDA LinkGeneric 01/2020 - 08/2007
2	Dosage Forms (Dosage Form)IBA 10/2018 - 01/2018
2	Urea (Carbamide)FDA LinkGeneric 09/2018 - 11/2005
2	Proteins (Proteins, Gene)FDA Link 09/2018 - 01/2017
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2018 - 08/2015
2	Bronchodilator Agents (Bronchodilators)IBA 01/2018 - 03/2004
2	Cilostazol (Pletal)FDA LinkGeneric 01/2018 - 11/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 08/2008
2	AcidsIBA 01/2017 - 08/2007
2	Interleukin-6 (Interleukin 6)IBA 08/2016 - 10/2003
2	ElectrolytesIBA 08/2010 - 12/2009
2	LipidsIBA 09/2008 - 10/2003
1	mitochondrial K(ATP) channelIBA 01/2022
1	KATP ChannelsIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Acetylserotonin O-Methyltransferase (Hydroxyindole O Methyltransferase)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	insulin receptor-related receptor (IRR)IBA 10/2021
1	Corn Oil (Oil, Corn)IBA 08/2021
1	coenzyme Q10 (CoQ10)IBA 08/2021
1	LithiumIBA 04/2021
1	BilirubinIBA 01/2021

Therapy/Procedure

14	Therapeutics 10/2021 - 09/2002
4	Renal Dialysis (Hemodialysis) 01/2022 - 01/2017
2	Ligation 01/2021 - 01/2016
2	Nephrectomy 08/2015 - 02/2013
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2008 - 10/2003